<unk> (nasal) is an anticholinergic agent that is FDA approved for the {{{indicationType}}} of symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children age 5 years and older.   Common adverse reactions include abnormal taste in mouth, bitter, xerostomia, bronchitis, nasal mucosa dryness and sinusitis.
Ipratropium 
Xamoterol
Levosalbutamol
Tulobuterol
Zafirlukast
Mizolastine
Pirbuterol
Seratrodast